Activation of the PI3K signaling pathway in pediatric cancer has been reported for both hematologic (Min et al., 2003; Steelman et al., 2004) and solid tumors [reviewed in (Loh et al., 2013)]. This evidence concerns the gene PIK3CA and childhood malignant neoplasm.